<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>p57(KIP2) is an imprinted gene located at the chromosomal locus 11p15.5 </plain></SENT>
<SENT sid="1" pm="."><plain>It is a cyclin-dependent kinase inhibitor belonging to the CIP/KIP family, which includes additionally p21(CIP1/WAF1) and p27(KIP1) </plain></SENT>
<SENT sid="2" pm="."><plain>It is the least studied CIP/KIP member and has a unique role in embryogenesis </plain></SENT>
<SENT sid="3" pm="."><plain>p57(KIP2) regulates the cell cycle, although novel functions have been attributed to this protein including cytoskeletal organization </plain></SENT>
<SENT sid="4" pm="."><plain>Molecular analysis of animal models and patients with <z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann Syndrome</z:e> have shown its nodal implication in the pathogenesis of this syndrome </plain></SENT>
<SENT sid="5" pm="."><plain>p57(KIP2) is frequently down-regulated in many common human <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> through several mechanisms, denoting its anti-oncogenic function </plain></SENT>
<SENT sid="6" pm="."><plain>This review is a thorough analysis of data available on p57(KIP2), in relation to p21(CIP1/WAF1) and p27(KIP1), on gene and protein structure, its transcriptional and translational regulation, and its role in human <z:mp ids='MP_0001532'>physiology</z:mp> and pathology, focusing on <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> development </plain></SENT>
</text></document>